Quest Diagnostics Incorporated (DGX) Hit a 52 Week High, Can the Run Continue?

zacks.com · 2026-08-21

Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

TickrTrends take: Quest Diagnostics has reached its 52 week high, which presents a valuation consideration for investors monitoring the Healthcare sector stock. Given TickrTrends' current assessment that DGX is overvalued, the continuation of this upward price movement would likely increase the gap between the stock's current market price and its derived valuation metrics. Investors focused on valuation should observe whether the stock's momentum sustains or whether mean reversion occurs as valuations become more stretched.

Read the full story at zacks.com →